comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Onclive tv - Page 1 : comparemela.com
Dr Obeng-Gyasi on Neighborhood Opportunity and Mortality in Breast Cancer
Samilia Obeng-Gyasi, MD, MPH, discusses a retrospective study on neighborhood opportunity and all-cause mortality in patients with breast cancer.
Samilia-obeng-gyasi
Cancer-center
Division-of-surgical-oncology
Ohio-state-university
Cancer-control-program
Surgical-oncology
The-ohio-state-university-comprehensive-cancer-center-james-hospital-amp-solove-research-institute-osuccc-
Onclive-tv
Breast-cancer
Disparities-in-cancer-care
Dr Jagannath on the ODAC Meeting on the Safety of Cilta-Cel in R/R Multiple Myeloma
Sundar Jagannath, MBBS, discusses takeaways from the FDA’s ODAC consensus on safety considerations with cilta-cel in relapsed/refractory multiple myeloma.
Sundar-jagannath
Oncologic-drugs-advisory-committee
Tisch-cancer-institute
Multiple-myeloma
Mount-sinai
Drugs-advisory-committee
The-tisch-cancer-institute-at-mount-sinai
Onclive-tv
Multiple-myeloma
Dr Siefker-Radtke on Toxicities With Enfortumab Vedotin Plus Pembrolizumab in Bladder Cancer
Arlene O. Siefker-Radtke, MD, discusses toxicities associated with enfortumab vedotin plus pembrolizumab in patients with bladder cancer.
Texas
United-states
Arleneo-siefker-radtke
University-of-texas-md-anderson-cancer-center
Department-of-genitourinary-medical-oncology
Division-of-cancer-medicine
Genitourinary-medical-oncology
Cancer-medicine
Cancer-center
Stevens-johnson-syndrome
Onclive-tv
Dr Lenz on the Association Between HER2 Expression and Treatment Outcomes in mCRC
Heinz-Josef Lenz, MD, FACP, discusses the association between HER2 expression and treatment outcomes in metastatic colorectal cancer.
Heinz-josef-lenz
Clinical-research
Department-of-medicine
Gastrointestinal-oncology-program
Colorectal-center
Division-of-oncology
Department-of-preventive-medicine
Keck-school-of-medicine
Preventive-medicine
Keck-school
Usc-norris-comprehensive-cancer-center
Dr Cobain on Endocrine Therapy–Based Treatment Strategies in HR+/HER2– Breast Cancer
Erin Frances Cobain, MD, discusses optimal endocrine therapy–based treatment strategies in later-line settings for HR-positive/HER2-negative breast cancer.
Michigan
United-states
Erin-frances-cobain
University-of-michigan
Rogel-cancer-center
Breast-cancer-clinical-research-team
University-of-michigan
Onclive-tv
Breast-cancer
vimarsana © 2020. All Rights Reserved.